Movement disorders in adults with 22q11 deletion syndrome by McNeill, A.
This is a repository copy of Movement disorders in adults with 22q11 deletion syndrome.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/143775/
Version: Accepted Version
Article:
McNeill, A. (2019) Movement disorders in adults with 22q11 deletion syndrome. Movement
Disorders Clinical Practice. ISSN 2330-1619 
https://doi.org/10.1002/mdc3.12752
This is the peer reviewed version of the following article: McNeill, A. (2019), Movement 
disorders in adults with 22q11 deletion syndrome. Mov Disord Clin Pract., which has been 
published in final form at https://doi.org/10.1002/mdc3.12752. This article may be used for 
non-commercial purposes in accordance with Wiley Terms and Conditions for Use of 
Self-Archived Versions.
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless 
indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by 
national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of 
the full text version. This is indicated by the licence information on the White Rose Research Online record 
for the item. 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
Movement disorders in adults with 22q11 deletion syndrome 
 
Alisdair McNeill FRCP Edin PhD DCH,  
Department of Neuroscience, 
The University of Sheffield. 
385a Glossop Road. 
Sheffield. 
S10 2HQ. 
a.mcneill@sheffield.ac.uk  
 
word count: 303 words  
Key words: 
TGHOHWLRQV\QGURPH3DUNLQVRQ¶VGLVHDVH 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A
cc
ep
te
d
 A
rt
ic
le
This article is protected by copyright. All rights reserved.
 
This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which 
may lead to differences between this version and the Version of Record. Please cite this 
article as doi: 10.1002/mdc3.12752
Dear Sir, 
 
,UHDGZLWKJUHDWLQWHUHVWWKHUHFHQWUHYLHZDUWLFOHE\%RRWHWDORQ3DUNLQVRQ¶VGLVHDVHLQ
22q11 deletion syndrome1.  7KHUHLVHYLGHQFHWRVXJJHVWDQLQFUHDVHGULVNRI3DUNLQVRQ¶V
disease among people with 22q11 deletion syndrome.  In our study of 50 adults with 22q11 
deletion syndrome, we identified an increased prevalence of potential clinical markers of 
prodromal neurodegeneration (e.g. hyposmia)2:HIXOO\DJUHHZLWK%RRW¶VDUJXPHQWWKDW
the core clinical features of 22q11 deletion syndrome may account for the presence of some 
of these apparent prodromal markers.  We also identified a significantly increased 
prevalence of symptoms of REM sleep behaviour disorder in our cohort.  Formal sleep 
studies in people with 22q11 deletion should be performed to try and identify the prevalence 
and significance of REM sleep disorder in 22q11.  The 22q11 deletion syndrome offers a 
genetically defined group in which to study prodromal PD and development of the motor 
features of PD.  However, we need to consider which clinical features to use as prodromal 
markers to make sure we are not simply detecting core clinical features of 22q11 (e.g. 
hyposmia associated with upper airways malformation).   
Chromosome microdeletions frequently cause disease through hapolinsufficiency for genes 
in the deletion region (or deletion of genes at the breakpoint)3,4.  There are several 
interesting candidates within the 22q11 deletion; involved in dopamine metabolism, 
mitochondrial function or microRNA processing.  No single nucleotide variants in any of 
these candidate genes have been reported in PD cases to my knowledge.  The deletion is 
due to non-allelic homologous recombination (NAHR) and therefore is of a consistent size, 
precluding identification of a critical region.   The molecular mechanisms explaining 
increased PD risk in 22q11 remain open for exploration.  Once again it will be crucial to 
disentangle mechanisms which are core to the 22q11 deletion phenotype from those which 
might explain increased PD risk.    
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